Back

Therapeutic modulation of the lung microenvironment in obesity-induced heart failure with preserved ejection fraction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Cardiac remodeling and multiorgan interactions in heart failure Hypertension, Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marialucia Telesca

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

8 More presentations in this session

Presentation thumbnail
Discussant - Cardiac remodelling and multiorgan interactions in heart failure
Presentation thumbnail
A Novel CKD-HFpEF model for exploring neurogenic mechanisms in cardiorenal interactions: kidney surface ablation without renal nerve removal
Mr R. Miyamoto (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
The cardio-hepatic interaction mediated by selenoprotein P is important for the pathogenesis of heart failure.
Associate Professor S. Usui (Kanazawa, JP)
Abstract
Presentation thumbnail
Transcriptomic profiles of ischemic and non-ischemic right ventricular heart failure
Doctor Y. Devaux (Luxembourg, LU)
Abstract Slides Video
Presentation thumbnail
Nuclear AGO2 exacerbated high-fat diet-induced heart failure by activating transcription of HMGCS2 to promote ketogenesis in the heart
Doctor K. Jin (Wuhan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Cardiac remodeling and multiorgan interactions in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Effects of BET Inhibition on lung micro-environmental changes in obesity-related pulmonary Arterial Hypertension (PAH)
thumbnail
Congress Presentation
The epi-drug RVX-208 restores autophagy in cardiometabolic heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources